Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H20N6O |
Molecular Weight | 264.3268 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=C2N=CN(CCNCCCCCO)C2=NC=N1
InChI
InChIKey=CVPTTZZCRDVGSU-UHFFFAOYSA-N
InChI=1S/C12H20N6O/c13-11-10-12(16-8-15-11)18(9-17-10)6-5-14-4-2-1-3-7-19/h8-9,14,19H,1-7H2,(H2,13,15,16)
DescriptionCurator's Comment: description was created based on several sources, including:
https://idsa.confex.com/idsa/2008/webprogram/Paper26299.html
Curator's Comment: description was created based on several sources, including:
https://idsa.confex.com/idsa/2008/webprogram/Paper26299.html
NB-001, an oil-in-water emulsion containing high energy nanometer-sized droplets stabilized by surfactants is designed for topical treatment of herpes labialis infections. NB-001 diffuses through the stratum corneum via the follicular route to accumulate in the epidermal and dermal tissues, without disrupting the normal epithelial matrix. The concentrations achieved in the epidermis and dermis are well above the concentrations required for antiviral activity.
Originator
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
0.5 % 5 times / day multiple, topical Highest studied dose Dose: 0.5 %, 5 times / day Route: topical Route: multiple Dose: 0.5 %, 5 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Condition: herpes simplex Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Sample Use Guides
Subjects applied 200 µL of NB-001 (0.1%, 0.3%, 0.5%) 5 times daily for a maximum of 4 days.
Route of Administration:
Topical
Strains of HSV-1and HSV-2 (3 x 105 - 7.5 x 106 pfu/ml) were exposed to different concentrations of NB-001 for 15 minutes at room temperature and residual live virus was measured in a standard plaque-forming assay. The IC95 values of NB-001 against either HSV-1 or -2 virus ranged from 3 - 14 μg/ml.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB12716
Created by
admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
|
PRIMARY | |||
|
J89QT81NBQ
Created by
admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
|
PRIMARY | |||
|
686301-48-4
Created by
admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
|
PRIMARY | |||
|
DTXSID30384648
Created by
admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
|
PRIMARY | |||
|
2815031
Created by
admin on Sat Dec 16 08:18:01 GMT 2023 , Edited by admin on Sat Dec 16 08:18:01 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD